RegulyzeMahameda
Mahameda is a botanical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 5-10 g. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 5-10 g | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Mahameda
Mahameda is tracked in the Regulyze Ingredient Intelligence database as a botanical. The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Mahameda permitted in nutraceuticals under FSSAI (India)?
Mahameda is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Mahameda?
The permitted level recorded for Mahameda is 5-10 g. Limits can vary by product type and market — confirm against the current regulation.
What product category does Mahameda belong to?
Mahameda is classified under: Botanicals.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.